This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04455/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04455/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04455/identifier/chebi/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04455/identifier/pdb/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04455/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04455
rdf:type
n3:Drug
n3:description
A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)
n3:group
experimental
owl:sameAs
n7:DB04455 n14:DB04455
dcterms:title
Trimethyl Glycine
adms:identifier
n9:DB04455 n10:BET n11:41139 n12:248 n13:46506049
n3:IUPAC-Name
n5:271B5B7D-363D-11E5-9242-09173F13E4C5
n3:InChI
n5:271B5B83-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n5:271B5B82-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n5:271B5B7F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n5:271B5B80-363D-11E5-9242-09173F13E4C5
n3:SMILES
n5:271B5B81-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n5:271B5B7B-363D-11E5-9242-09173F13E4C5
n3:logP
n5:271B5B7C-363D-11E5-9242-09173F13E4C5 n5:271B5B79-363D-11E5-9242-09173F13E4C5
n3:logS
n5:271B5B7A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n5:271B5B89-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n5:271B5B8A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n5:271B5B84-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n5:271B5B85-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n5:271B5B87-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n5:271B5B86-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n5:271B5B88-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n5:271B5B8E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n5:271B5B90-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n5:271B5B91-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n5:271B5B8D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n5:271B5B8C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n5:271B5B8F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n5:271B5B7E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n5:271B5B8B-363D-11E5-9242-09173F13E4C5